v3.25.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from (used in) operating activities:    
Net (loss) income $ (36,741) $ 7,334
Adjustments to reconcile net income to net cash from operating activities:    
Accretion of asset retirement obligations 1,206 1,063
Depreciation, depletion, and amortization 51,671 48,909
Amortization of debt issuance costs 1,579 664
Stock-based compensation 12,844 13,255
(Gain)/loss on disposal of equipment (18)
Deferred income taxes (9,641) 221
Changes in operating assets and liabilities:    
Accounts receivable 29,970 33,961
Prepaid expenses and other current assets 7,990 5,895
Inventories (38,216) (15,888)
Other assets and liabilities (285) (2,504)
Accounts payable (3,650) 2,576
Accrued liabilities 3,611 1,515
Net cash from operating activities 20,338 96,983
Cash flows from (used in) investing activities:    
Capital expenditures (50,139) (44,634)
Maben preparation plant capital expenditures (1,948) (12,288)
Capitalized interest (939) (998)
Mineral rights acquisition (3,378)
Other 261 (182)
Net cash used in investing activities (56,143) (58,102)
Cash flows from (used in) financing activities:    
Proceeds from equity offering 189,000
Payment of equity offering costs (913)
Proceeds from senior notes 64,931
Proceeds from borrowings 52,000 136,500
Repayment of borrowings (52,282) (149,921)
Repayments of senior notes (34,500)
Proceeds from stock options exercised 802 534
Payment of dividends (4,340) (24,474)
Repayments of insurance financing (4,019) (4,032)
Repayments of equipment finance leases (7,041) (6,740)
Payment of debt issuance costs (3,505)
Shares surrendered for withholding taxes payable (3,491) (9,846)
Net cash from (used in) financing activities 196,642 (57,979)
Net change in cash and cash equivalents and restricted cash 160,837 (19,098)
Cash and cash equivalents and restricted cash, beginning of period 33,823 42,781
Cash and cash equivalents and restricted cash, end of period 194,660 23,683
Cash and cash equivalents 193,846 22,864
Restricted cash 814 819
Total cash, cash equivalents and restricted cash 194,660 23,683
Non-cash investing and financing activities:    
Leased assets obtained under new financing leases 13,227 9,187
Capital expenditures included in accounts payable and accrued liabilities 8,656 4,584
Accrued dividends and dividend equivalents payable $ 34 $ 735